Nurse Practitioner, Family · Doral, FL
NPI
1497261895
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2441 NW 93rd Ave Ste 102
Doral, FL, 33172
Phone (786) 361-4464
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$257K
3,295 prescriptions
Company payments, 2025
$2,933
From 17 companies
Medicare prescription drug claims, 2024
In 2024, the drug Minerva Perez prescribed most often to Medicare patients was Metformin Hcl, with 119 prescriptions and refills. In total Minerva Perez wrote 3,295 Medicare prescriptions that cost $257K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Generic | 119 | 248 | 37 | $983 |
| Amlodipine Besylate Generic | 115 | 260 | 40 | $986 |
| Levothyroxine Sodium Generic | 111 | 227 | 35 | $1,586 |
| Atorvastatin Calcium Generic | 110 | 296 | 45 | $1,327 |
| Losartan Potassium Generic | 105 | 242 | 37 | $937 |
| Lisinopril Generic | 96 | 175 | 24 | $564 |
| Clonazepam Generic | 96 | 100 | 24 | $734 |
| Rosuvastatin Calcium Generic | 82 | 199 | 33 | $1,080 |
| Omeprazole Generic | 72 | 164 | 36 | $1,210 |
| Simvastatin Generic | 65 | 124 | 23 | $455 |
| Montelukast Sodium Generic | 64 | 145 | 23 | $871 |
| Alprazolam Generic | 64 | 64 | 12 | $229 |
| Azithromycin Generic | 58 | 58 | 47 | $266 |
| Famotidine Generic | 57 | 98 | 17 | $708 |
| Metoprolol Succinate Generic | 57 | 124 | 16 | $942 |
Brand drugs: 376 claims; generic drugs: 2,899 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Minerva Perez $2,933 ($2,933 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $616.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $616 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 12 | $457 |
| Abbvie Inc. ABBV | 15 | $450 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $371 |
| GlaxoSmithKline, LLC. GSK | 3 | $173 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $118 |
| Pfizer Inc. PFE | 4 | $91.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.